Introduction:

Endovascular papillary angioendothelioma, also known as Dabska tumor or papillary intralymphatic angioendothelioma, is a rare vascular tumor that predominantly affects children and young adults. This comprehensive article aims to provide an in-depth understanding of the clinical features, diagnosis, treatment, and prognosis of endovascular papillary angioendothelioma.

Understanding Endovascular Papillary Angioendothelioma:

Endovascular papillary angioendothelioma is a low-grade malignant tumor that primarily arises in the skin and subcutaneous tissues. It is characterized by the formation of papillary structures within dilated lymphatic vessels. Although rare, this tumor has the potential for local invasion and metastasis to regional lymph nodes.

Clinical Features:

Endovascular papillary angioendothelioma can present with various clinical features, including:

• Skin lesions: The most common manifestation is a painless, slow-growing nodule or mass in the skin or subcutaneous tissues. These lesions are typically bluish-red or violaceous in color and may be associated with surrounding erythema or edema.
• Lymph node enlargement: In some cases, regional lymph nodes may become enlarged and palpable due to metastasis from the primary tumor.
• Systemic symptoms: Rarely, patients may experience systemic symptoms such as fever, fatigue, or weight loss. These symptoms are more common in cases with extensive disease involvement.

Diagnosis:

The diagnosis of endovascular papillary angioendothelioma involves several steps, including:

• Clinical evaluation: A thorough physical examination and medical history review are conducted to assess the presenting symptoms and characteristics of the skin lesions.
• Imaging studies: Imaging techniques such as ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT) scans may be used to evaluate the extent of the tumor, assess lymph node involvement, and identify potential distant metastases.
• Biopsy: A biopsy of the skin lesion or affected tissue is performed to obtain a tissue sample for microscopic examination. Histopathological analysis reveals characteristic papillary structures within dilated lymphatic vessels.
• Immunohistochemistry: Immunohistochemical staining is performed on the tissue sample to identify specific markers associated with endovascular papillary angioendothelioma, such as endothelial cell markers (CD31, CD34) and lymphatic markers (D2-40).

Treatment and Prognosis:

The treatment of endovascular papillary angioendothelioma is primarily surgical, with the goal of complete tumor resection. Depending on the extent of the disease, surgical options may include wide local excision, lymph node dissection, or amputation in advanced cases. Adjuvant therapies such as radiotherapy or chemotherapy may be considered in certain cases, particularly if there is evidence of lymph node involvement or metastasis.

The prognosis of endovascular papillary angioendothelioma is generally favorable, especially for localized tumors that are completely resected. However, cases with extensive disease involvement, lymph node metastasis, or recurrent tumors may have a less favorable prognosis. Long-term follow-up is necessary to monitor for potential tumor recurrence or metastasis.

Conclusion:

Endovascular papillary angioendothelioma is a rare vascular tumor that predominantly affects children and young adults. By understanding its clinical features, diagnosis, treatment, and prognosis, healthcare professionals can provide appropriate management strategies and surveillance for patients with this rare tumor.

Hashtags: #EndovascularPapillaryAngioendothelioma #DabskaTumor #VascularTumor #SkinLesions